Bone Biologics (BBLG) Announces 1-for-6 Reverse Stock Split

Go back to Bone Biologics (BBLG) Announces 1-for-6 Reverse Stock Split

Bone Biologics Announces 1-for-6 Reverse Stock Split

June 6, 2025 8:00 AM EDT

BURLINGTON, Mass.--(BUSINESS WIRE)--

Bone Biologics Corporation (Bone Biologics or the Company) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, today announced a planned reverse stock split of its shares of common stock at a ratio of 1-for-6. The reverse stock split will take effect as of 12:01 a.m. ET, on Tuesday, June 10, 2025, and shares of Bone Biologics are expected to trade on a post-split basis on Nasdaq under the existing trading symbol, BBLG, at the market open on June 10, 2025.

At the Companys annual meeting of stockholders held on May 30,... More